The updated version of the 21st Century Cures Act was approved by the House on Wednesday, the 30th of November, and it is expected to have similar success in the Senate vote next week. This will be welcomed news for patients, advocacy groups, and pharmaceutical companies alike, who will all stand to gain in some way, if the Bill is passed into law.

For more information on this latest win for the 21st Century Cures Act, click here to access the full original article.